Suchergebnisse - "ANTIBIOTICS"

Epirubicin-loaded porous wollastonite nanoparticles for colorectal cancer therapy: synthesis, characterization, and in vivo study.

Autoren: Mahmoudi A Sadi KS Charmforoushan A et al.

Quelle: International journal of pharmaceutics [Int J Pharm] 2025 Dec 25; Vol. 686, pp. 126318. Date of Electronic Publication: 2025 Oct 30.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Elsevier/North-Holland Biomedical Press Country of Publication: Netherlands NLM ID: 7804127 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-3476 (Electronic) Linking ISSN: 03785173 NLM ISO Abbreviation: Int J Pharm Subsets: MEDLINE

MeSH-Schlagworte: Silicates*/chemistry , Silicates*/administration & dosage , Calcium Compounds*/chemistry , Calcium Compounds*/administration & dosage , Nanoparticles*/chemistry , Nanoparticles*/administration & dosage , Colorectal Neoplasms*/drug therapy , Colorectal Neoplasms*/pathology , Colorectal Neoplasms*/metabolism , Epirubicin*/administration & dosage , Epirubicin*/pharmacokinetics , Epirubicin*/chemistry , Epirubicin*/pharmacology , Antibiotics, Antineoplastic*/administration & dosage , Antibiotics, Antineoplastic*/pharmacokinetics , Antibiotics, Antineoplastic*/chemistry , Drug Carriers*/chemistry, Animals ; Mice, Inbred BALB C ; Cell Line, Tumor ; Drug Liberation ; Tissue Distribution ; Porosity ; Mice ; Particle Size ; Humans ; Cell Survival/drug effects ; Female

Advanced internally bridged silica core-shell nanocarriers: Design and applications.

Autoren: Heidari Nia M Heidari Nia S Munguia-Lopez JG et al.

Quelle: Journal of colloid and interface science [J Colloid Interface Sci] 2025 Dec 15; Vol. 700 (Pt 3), pp. 138627. Date of Electronic Publication: 2025 Aug 06.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Academic Press Country of Publication: United States NLM ID: 0043125 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-7103 (Electronic) Linking ISSN: 00219797 NLM ISO Abbreviation: J Colloid Interface Sci Subsets: MEDLINE

MeSH-Schlagworte: Silicon Dioxide*/chemistry , Doxorubicin*/pharmacology , Doxorubicin*/chemistry , Drug Carriers*/chemistry , Nanostructures*/chemistry , Antibiotics, Antineoplastic*/pharmacology , Antibiotics, Antineoplastic*/chemistry , Nanoparticles*/chemistry, Humans ; Surface Properties ; Particle Size ; Cell Survival/drug effects ; Drug Liberation

Electrostatically driven supramolecular drug-carrier system for targeted, efficient, safer Cancer chemotherapy.

Autoren: Chiu PY Chen JK Cheng CC

Quelle: Journal of colloid and interface science [J Colloid Interface Sci] 2025 Dec 15; Vol. 700 (Pt 1), pp. 138360. Date of Electronic Publication: 2025 Jul 05.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Academic Press Country of Publication: United States NLM ID: 0043125 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-7103 (Electronic) Linking ISSN: 00219797 NLM ISO Abbreviation: J Colloid Interface Sci Subsets: MEDLINE

MeSH-Schlagworte: Doxorubicin*/chemistry , Doxorubicin*/pharmacology , Drug Carriers*/chemistry , Chitosan*/chemistry , Rhodamines*/chemistry , Rhodamines*/pharmacology , Antineoplastic Agents*/pharmacology , Antineoplastic Agents*/chemistry , Drug Delivery Systems* , Antibiotics, Antineoplastic*/pharmacology , Antibiotics, Antineoplastic*/chemistry, Humans ; Static Electricity ; HeLa Cells ; Particle Size ; Apoptosis/drug effects ; Drug Liberation ; Cell Survival/drug effects ; Surface Properties ; Drug Screening Assays, Antitumor

Reducing Daunorubicin in Induction Therapy in Children With B-Lineage ALL With Favorable Prognosis: Results of Phase III Trial AIEOP-BFM ALL 2009.

Autoren: Gottschalk H Möricke A Conter V et al.

Quelle: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2025 Dec 10; Vol. 43 (35), pp. 3739-3749. Date of Electronic Publication: 2025 Nov 10.

Publikationsart: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial; Multicenter Study

Info zur Zeitschrift: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

MeSH-Schlagworte: Daunorubicin*/administration & dosage , Daunorubicin*/adverse effects , Induction Chemotherapy* , Antibiotics, Antineoplastic*/administration & dosage , Antibiotics, Antineoplastic*/adverse effects , Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy , Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*/mortality, Humans ; Child ; Female ; Adolescent ; Male ; Child, Preschool ; Infant ; Prognosis ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use

Focused ultrasound-triggered doxorubicin liposomes reshape tumor microenvironment to boost checkpoint depletion in triple-negative breast cancer model.

Autoren: Lee SN Choi JH Moon H et al.

Quelle: Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2025 Dec 10; Vol. 388 (Pt 2), pp. 114389. Date of Electronic Publication: 2025 Nov 04.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 8607908 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-4995 (Electronic) Linking ISSN: 01683659 NLM ISO Abbreviation: J Control Release Subsets: MEDLINE

MeSH-Schlagworte: Doxorubicin*/administration & dosage , Doxorubicin*/analogs & derivatives , Triple Negative Breast Neoplasms*/drug therapy , Triple Negative Breast Neoplasms*/immunology , Triple Negative Breast Neoplasms*/therapy , Triple Negative Breast Neoplasms*/pathology , Tumor Microenvironment*/drug effects , Immune Checkpoint Inhibitors*/administration & dosage , Antibiotics, Antineoplastic*/administration & dosage , Antibiotics, Antineoplastic*/therapeutic use, Animals ; Female ; Mice ; Liposomes ; Humans ; Cell Line, Tumor ; Immunotherapy/methods ; Polyethylene Glycols

Multi-interfacial microbubbles controlled sequential cavitation for synergistic vascular destruction/chemotherapeutic therapy.

Autoren: Chen T Zhang C Zhao Y et al.

Quelle: Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2025 Dec 10; Vol. 388 (Pt 1), pp. 114287. Date of Electronic Publication: 2025 Oct 01.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 8607908 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-4995 (Electronic) Linking ISSN: 01683659 NLM ISO Abbreviation: J Control Release Subsets: MEDLINE

MeSH-Schlagworte: Doxorubicin*/administration & dosage , Doxorubicin*/therapeutic use , Doxorubicin*/chemistry , Doxorubicin*/pharmacokinetics , Microbubbles* , Antibiotics, Antineoplastic*/administration & dosage , Antibiotics, Antineoplastic*/therapeutic use , Neoplasms*/drug therapy, Animals ; Nanoparticles/chemistry ; Nanoparticles/administration & dosage ; Humans ; Silicon Dioxide/chemistry ; Silicon Dioxide/administration & dosage ; Drug Delivery Systems ; Cell Line, Tumor ; Mice ; Female

Hydroxyapatite and doxorubicin-laden nanotherapeutics for effective multimodality cancer treatment boosted via mitochondrial calcium overload.

Autoren: Chang YS Sabu A Kandel M et al.

Quelle: Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2025 Dec 10; Vol. 388 (Pt 2), pp. 114368. Date of Electronic Publication: 2025 Nov 02.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 8607908 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-4995 (Electronic) Linking ISSN: 01683659 NLM ISO Abbreviation: J Control Release Subsets: MEDLINE

MeSH-Schlagworte: Doxorubicin*/administration & dosage , Doxorubicin*/therapeutic use , Doxorubicin*/chemistry , Calcium*/metabolism , Durapatite*/chemistry , Durapatite*/administration & dosage , Nanoparticles*/chemistry , Nanoparticles*/administration & dosage , Antibiotics, Antineoplastic*/administration & dosage , Antibiotics, Antineoplastic*/therapeutic use , Triple Negative Breast Neoplasms*/therapy , Triple Negative Breast Neoplasms*/pathology , Triple Negative Breast Neoplasms*/drug therapy, Animals ; Humans ; Female ; Cell Line, Tumor ; Mitochondria/metabolism ; Mitochondria/drug effects ; Bismuth/chemistry ; Bismuth/administration & dosage ; Cell Survival/drug effects ; Mice, Nude ; Combined Modality Therapy ; Mice ; Mice, Inbred BALB C ; Silicon Dioxide/chemistry ; Sulfides/chemistry ; Sulfides/administration & dosage ; Photothermal Therapy ; Polyethylene Glycols/chemistry

Biomimetic immortalized mesenchymal stem cell-based nanoparticles suppress orthotopic postsurgical glioma via CD73 targeting and chemotherapy.

Autoren: Zhang Y Wang Y Li B et al.

Quelle: Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2025 Dec 10; Vol. 388 (Pt 1), pp. 114297. Date of Electronic Publication: 2025 Oct 07.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 8607908 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-4995 (Electronic) Linking ISSN: 01683659 NLM ISO Abbreviation: J Control Release Subsets: MEDLINE

MeSH-Schlagworte: Glioma*/drug therapy , Glioma*/pathology , Glioma*/surgery , Glioma*/metabolism , Glioma*/therapy , Mesenchymal Stem Cells*/metabolism , Nanoparticles*/chemistry , Nanoparticles*/administration & dosage , Doxorubicin*/administration & dosage , Doxorubicin*/therapeutic use , Brain Neoplasms*/drug therapy , Brain Neoplasms*/pathology , Brain Neoplasms*/surgery , Brain Neoplasms*/therapy , 5'-Nucleotidase*/metabolism , 5'-Nucleotidase*/genetics , Biomimetic Materials*/administration & dosage , Biomimetic Materials*/chemistry , Antibiotics, Antineoplastic*/administration & dosage , Antibiotics, Antineoplastic*/therapeutic use, Animals ; Humans ; Cell Line, Tumor ; Blood-Brain Barrier/metabolism ; Mice, Nude ; Mice ; Apoptosis/drug effects ; Mice, Inbred BALB C ; Cell Proliferation/drug effects

Enhancing TIM-3 immunotherapy with epirubicin-loaded pH sensitive fusion membrane nanoparticles for effective glioblastoma treatment.

Autoren: Zhu D Zhu Y Yang X et al.

Quelle: Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2025 Dec 10; Vol. 388 (Pt 2), pp. 114367. Date of Electronic Publication: 2025 Oct 28.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 8607908 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-4995 (Electronic) Linking ISSN: 01683659 NLM ISO Abbreviation: J Control Release Subsets: MEDLINE

MeSH-Schlagworte: Glioblastoma*/drug therapy , Glioblastoma*/immunology , Glioblastoma*/therapy , Glioblastoma*/pathology , Hepatitis A Virus Cellular Receptor 2*/immunology , Hepatitis A Virus Cellular Receptor 2*/antagonists & inhibitors , Epirubicin*/administration & dosage , Epirubicin*/therapeutic use , Nanoparticles*/chemistry , Nanoparticles*/administration & dosage , Brain Neoplasms*/immunology , Brain Neoplasms*/drug therapy , Brain Neoplasms*/therapy , Antibiotics, Antineoplastic*/administration & dosage , Antibiotics, Antineoplastic*/therapeutic use , Antibiotics, Antineoplastic*/pharmacokinetics, Animals ; Hydrogen-Ion Concentration ; Humans ; Mice ; Immunotherapy/methods ; Cell Line, Tumor ; Tumor Microenvironment/drug effects ; Blood-Brain Barrier/metabolism ; Female ; Mice, Inbred C57BL ; Immunogenic Cell Death/drug effects ; Macrophages ; Peptides/chemistry

Injectable sustained local release doxorubicin depot technology- a promising adjuvant to systemic treatment?

Autoren: Jørgensen AR Hansen AE Henriksen JR et al.

Quelle: Drug delivery and translational research [Drug Deliv Transl Res] 2025 Dec; Vol. 15 (12), pp. 4601-4610. Date of Electronic Publication: 2025 Apr 03.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Springer Country of Publication: United States NLM ID: 101540061 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2190-3948 (Electronic) Linking ISSN: 2190393X NLM ISO Abbreviation: Drug Deliv Transl Res Subsets: MEDLINE

MeSH-Schlagworte: Doxorubicin*/administration & dosage , Doxorubicin*/pharmacokinetics , Doxorubicin*/chemistry , Doxorubicin*/therapeutic use , Antibiotics, Antineoplastic*/administration & dosage , Antibiotics, Antineoplastic*/pharmacokinetics , Antibiotics, Antineoplastic*/chemistry , Colorectal Neoplasms*/drug therapy , Colorectal Neoplasms*/pathology, Animals ; Female ; Delayed-Action Preparations/administration & dosage ; Delayed-Action Preparations/pharmacokinetics ; Mice ; Swine ; Injections, Subcutaneous ; Cell Line, Tumor ; Drug Liberation

Application of Idarubicin loaded Equalspheres in the TACE procedure for Rabbit Liver Tumor Model.

Autoren: Lu H Yao Z Li Y et al.

Quelle: Academic radiology [Acad Radiol] 2025 Dec; Vol. 32 (12), pp. 7353-7362. Date of Electronic Publication: 2025 Oct 04.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Association Of University Radiologists Country of Publication: United States NLM ID: 9440159 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-4046 (Electronic) Linking ISSN: 10766332 NLM ISO Abbreviation: Acad Radiol Subsets: MEDLINE

MeSH-Schlagworte: Idarubicin*/administration & dosage , Idarubicin*/pharmacokinetics , Chemoembolization, Therapeutic*/methods , Antibiotics, Antineoplastic*/administration & dosage , Antibiotics, Antineoplastic*/pharmacokinetics , Liver Neoplasms*/therapy , Liver Neoplasms*/drug therapy , Liver Neoplasms, Experimental*/therapy, Animals ; Rabbits ; Microspheres ; Disease Models, Animal

Safety of high-dose mitomycin C vs oxaliplatin HIPEC for peritoneal metastases.

Autoren: Sticca G Soucisse M Abou-Khalil M et al.

Quelle: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology [Eur J Surg Oncol] 2025 Dec; Vol. 51 (12), pp. 110534. Date of Electronic Publication: 2025 Oct 21.

Publikationsart: Journal Article; Comparative Study

Info zur Zeitschrift: Publisher: Elsevier Country of Publication: England NLM ID: 8504356 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-2157 (Electronic) Linking ISSN: 07487983 NLM ISO Abbreviation: Eur J Surg Oncol Subsets: MEDLINE

MeSH-Schlagworte: Mitomycin*/administration & dosage , Mitomycin*/adverse effects , Peritoneal Neoplasms*/secondary , Peritoneal Neoplasms*/therapy , Oxaliplatin*/administration & dosage , Oxaliplatin*/adverse effects , Hyperthermic Intraperitoneal Chemotherapy*/methods , Appendiceal Neoplasms*/pathology , Colorectal Neoplasms*/pathology , Antibiotics, Antineoplastic*/administration & dosage , Antibiotics, Antineoplastic*/adverse effects , Antineoplastic Agents*/administration & dosage, Humans ; Male ; Female ; Middle Aged ; Retrospective Studies ; Cytoreduction Surgical Procedures ; Aged ; Adult

Targeted cross-linking tumor extracellular matrix by genipin and doxorubicin co-loaded nanomedicine to efficiently inhibit tumor metastasis.

Autoren: Cui J Jiang J Feng L et al.

Quelle: Colloids and surfaces. B, Biointerfaces [Colloids Surf B Biointerfaces] 2025 Dec; Vol. 256 (Pt 1), pp. 115016. Date of Electronic Publication: 2025 Aug 07.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9315133 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-4367 (Electronic) Linking ISSN: 09277765 NLM ISO Abbreviation: Colloids Surf B Biointerfaces Subsets: MEDLINE

MeSH-Schlagworte: Iridoids*/chemistry , Iridoids*/pharmacology , Doxorubicin*/pharmacology , Doxorubicin*/chemistry , Extracellular Matrix*/drug effects , Extracellular Matrix*/metabolism , Extracellular Matrix*/chemistry , Nanomedicine*/methods , Cross-Linking Reagents*/chemistry , Cross-Linking Reagents*/pharmacology , Antibiotics, Antineoplastic*/pharmacology , Antibiotics, Antineoplastic*/chemistry, Animals ; Mice, Inbred BALB C ; Mice ; Female ; Drug Liberation ; Cell Line, Tumor ; Cell Movement/drug effects ; Cell Proliferation/drug effects ; Humans ; Particle Size ; Liposomes/chemistry ; Oligopeptides/chemistry

Comparison of the efficacy and safety of five-day methotrexate versus pulse actinomycin D for low-risk gestational trophoblastic neoplasia: a single-center historical cohort study ^☆ .

Autoren: Katayama E Usui H Nakamura N et al.

Quelle: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2025 Dec; Vol. 35 (12), pp. 102657. Date of Electronic Publication: 2025 Sep 10.

Publikationsart: Journal Article; Comparative Study

Info zur Zeitschrift: Publisher: Elsevier Country of Publication: United States NLM ID: 9111626 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-1438 (Electronic) Linking ISSN: 1048891X NLM ISO Abbreviation: Int J Gynecol Cancer Subsets: MEDLINE

MeSH-Schlagworte: Dactinomycin*/administration & dosage , Dactinomycin*/adverse effects , Gestational Trophoblastic Disease*/drug therapy , Gestational Trophoblastic Disease*/pathology , Methotrexate*/administration & dosage , Methotrexate*/adverse effects , Antimetabolites, Antineoplastic*/administration & dosage , Antimetabolites, Antineoplastic*/adverse effects , Antibiotics, Antineoplastic*/administration & dosage , Antibiotics, Antineoplastic*/adverse effects, Humans ; Female ; Pregnancy ; Adult ; Retrospective Studies ; Middle Aged ; Cohort Studies ; Drug Administration Schedule ; Young Adult

Investigating mTOR signaling pathway and sirolimus response in Benign lymphangioendothelioma.

Autoren: Wen X Zou D Ban F et al.

Quelle: The Journal of dermatological treatment [J Dermatolog Treat] 2025 Dec; Vol. 36 (1), pp. 2511114. Date of Electronic Publication: 2025 Jun 16.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Informa Healthcare Country of Publication: England NLM ID: 8918133 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1471-1753 (Electronic) Linking ISSN: 09546634 NLM ISO Abbreviation: J Dermatolog Treat Subsets: MEDLINE

MeSH-Schlagworte: Sirolimus*/therapeutic use , Sirolimus*/adverse effects , Sirolimus*/administration & dosage , TOR Serine-Threonine Kinases*/metabolism , TOR Serine-Threonine Kinases*/antagonists & inhibitors , MTOR Inhibitors*/therapeutic use , MTOR Inhibitors*/adverse effects , MTOR Inhibitors*/administration & dosage , Antibiotics, Antineoplastic*/therapeutic use , Antibiotics, Antineoplastic*/administration & dosage , Antibiotics, Antineoplastic*/adverse effects , Lymphangioma*/drug therapy , Lymphangioma*/pathology , Skin Neoplasms*/drug therapy , Skin Neoplasms*/pathology, Humans ; Signal Transduction/drug effects ; Male ; Female ; Adult ; Middle Aged ; Treatment Outcome ; Young Adult ; Administration, Oral

Electrochemotherapy, as a novel therapeutic approach in the management of lentigo maligna, lentigo maligna melanoma, and acral lentiginous melanoma.

Autoren: Rózsa P Csányi I Vass G et al.

Quelle: The Journal of dermatological treatment [J Dermatolog Treat] 2025 Dec; Vol. 36 (1), pp. 2495096. Date of Electronic Publication: 2025 Apr 29.

Publikationsart: Journal Article; Case Reports

Info zur Zeitschrift: Publisher: Informa Healthcare Country of Publication: England NLM ID: 8918133 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1471-1753 (Electronic) Linking ISSN: 09546634 NLM ISO Abbreviation: J Dermatolog Treat Subsets: MEDLINE

MeSH-Schlagworte: Antibiotics, Antineoplastic*/administration & dosage , Antibiotics, Antineoplastic*/therapeutic use , Bleomycin*/administration & dosage , Bleomycin*/therapeutic use , Electrochemotherapy*/methods , Hutchinson's Melanotic Freckle*/drug therapy , Hutchinson's Melanotic Freckle*/pathology , Melanoma*/drug therapy , Melanoma*/pathology , Skin Neoplasms*/drug therapy , Skin Neoplasms*/pathology, Aged ; Aged, 80 and over ; Female ; Humans ; Male ; Treatment Outcome

The Treatment of Adult Laryngeal Hemangiomas Located on the Arytenoids: Excision vs. Chemotherapy.

Autoren: Wu X Ma J Zhang J et al.

Quelle: Ear, nose, & throat journal [Ear Nose Throat J] 2025 Dec; Vol. 104 (12), pp. NP807-NP812. Date of Electronic Publication: 2023 Apr 16.

Publikationsart: Journal Article; Comparative Study

Info zur Zeitschrift: Publisher: SAGE Publications Country of Publication: United States NLM ID: 7701817 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1942-7522 (Electronic) Linking ISSN: 01455613 NLM ISO Abbreviation: Ear Nose Throat J Subsets: MEDLINE

MeSH-Schlagworte: Laryngeal Neoplasms*/therapy , Laryngeal Neoplasms*/drug therapy , Laryngeal Neoplasms*/surgery , Laryngeal Neoplasms*/pathology , Bleomycin*/administration & dosage , Bleomycin*/therapeutic use , Hemangioma*/drug therapy , Hemangioma*/therapy , Hemangioma*/surgery , Hemangioma*/pathology , Arytenoid Cartilage*/pathology , Arytenoid Cartilage*/surgery , Antibiotics, Antineoplastic*/administration & dosage , Antibiotics, Antineoplastic*/therapeutic use, Humans ; Male ; Female ; Middle Aged ; Adult ; Treatment Outcome ; Aged ; Retrospective Studies

Role of folate functionalized human serum albumin nano-formulation for bleomycin delivery on gene expression in gastric cancer cells.

Autoren: Kelkawi AHA Alnasraui AHF Al-Musawi S et al.

Quelle: Biochemical and biophysical research communications [Biochem Biophys Res Commun] 2025 Nov 28; Vol. 791, pp. 152922. Date of Electronic Publication: 2025 Nov 05.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Elsevier Country of Publication: United States NLM ID: 0372516 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1090-2104 (Electronic) Linking ISSN: 0006291X NLM ISO Abbreviation: Biochem Biophys Res Commun Subsets: MEDLINE

MeSH-Schlagworte: Folic Acid*/chemistry , Stomach Neoplasms*/drug therapy , Stomach Neoplasms*/genetics , Stomach Neoplasms*/pathology , Stomach Neoplasms*/metabolism , Bleomycin*/administration & dosage , Bleomycin*/pharmacology , Bleomycin*/chemistry , Serum Albumin, Human*/chemistry , Nanoparticles*/chemistry , Antibiotics, Antineoplastic*/administration & dosage , Antibiotics, Antineoplastic*/pharmacology , Antibiotics, Antineoplastic*/chemistry, Humans ; Cell Line, Tumor ; Drug Liberation ; Molecular Docking Simulation ; Cell Survival/drug effects ; Gene Expression Regulation, Neoplastic/drug effects ; Drug Carriers/chemistry ; Drug Delivery Systems

Chronotherapy as a novel strategy to limit anthracycline-induced cardiotoxicity.

Autoren: Kelters IR Printezi MI Ballesta A et al.

Quelle: Cardiovascular research [Cardiovasc Res] 2025 Nov 22; Vol. 121 (14), pp. 2144-2156.

Publikationsart: Journal Article; Review

Info zur Zeitschrift: Publisher: Oxford Journals Country of Publication: England NLM ID: 0077427 Publication Model: Print Cited Medium: Internet ISSN: 1755-3245 (Electronic) Linking ISSN: 00086363 NLM ISO Abbreviation: Cardiovasc Res Subsets: MEDLINE

MeSH-Schlagworte: Anthracyclines*/adverse effects , Anthracyclines*/administration & dosage , Anthracyclines*/pharmacokinetics , Circadian Rhythm*/drug effects , Heart Diseases*/chemically induced , Heart Diseases*/prevention & control , Heart Diseases*/physiopathology , Heart Diseases*/metabolism , Heart Diseases*/pathology , Antibiotics, Antineoplastic*/adverse effects , Antibiotics, Antineoplastic*/administration & dosage , Antibiotics, Antineoplastic*/pharmacokinetics , Drug Chronotherapy*, Humans ; Animals ; Cardiotoxicity ; Time Factors ; Risk Factors ; Treatment Outcome ; Oxidative Stress/drug effects ; Drug Administration Schedule

Cryo-Shocked Cancer Cell Biomimetic Carriers Enhance Tumor-Targeted Doxorubicin Delivery in Triple-Negative Breast Cancer.

Autoren: Wang H Xu L Lin Y et al.

Quelle: ACS applied materials & interfaces [ACS Appl Mater Interfaces] 2025 Nov 19; Vol. 17 (46), pp. 63116-63129. Date of Electronic Publication: 2025 Nov 05.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: American Chemical Society Country of Publication: United States NLM ID: 101504991 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1944-8252 (Electronic) Linking ISSN: 19448244 NLM ISO Abbreviation: ACS Appl Mater Interfaces Subsets: MEDLINE

MeSH-Schlagworte: Doxorubicin*/chemistry , Doxorubicin*/pharmacology , Doxorubicin*/pharmacokinetics , Doxorubicin*/therapeutic use , Triple Negative Breast Neoplasms*/drug therapy , Triple Negative Breast Neoplasms*/pathology , Triple Negative Breast Neoplasms*/metabolism , Drug Carriers*/chemistry , Biomimetic Materials*/chemistry , Antibiotics, Antineoplastic*/chemistry , Antibiotics, Antineoplastic*/pharmacology , Antineoplastic Agents*/chemistry , Antineoplastic Agents*/pharmacology, Animals ; Female ; Mice ; Cell Line, Tumor ; Humans ; Mice, Inbred BALB C ; Drug Delivery Systems ; Tissue Distribution ; Drug Liberation